Evolve Private Wealth LLC Takes Position in Cigna Group $CI

Evolve Private Wealth LLC acquired a new position in Cigna Group (NYSE:CI) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,887 shares of the health services provider’s stock, valued at approximately $796,000.

Several other large investors have also made changes to their positions in the business. Varma Mutual Pension Insurance Co bought a new stake in shares of Cigna Group in the second quarter valued at approximately $12,803,000. Westpac Banking Corp bought a new position in Cigna Group during the second quarter worth $504,000. TRB Wealth Management LLC bought a new position in Cigna Group during the second quarter worth $204,000. Sumitomo Life Insurance Co. acquired a new position in Cigna Group during the 2nd quarter valued at $898,000. Finally, Korea Investment CORP bought a new stake in Cigna Group in the 2nd quarter valued at $64,742,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 0.5%

Shares of CI opened at $276.19 on Monday. The stock’s fifty day simple moving average is $284.20 and its 200-day simple moving average is $281.45. The firm has a market capitalization of $72.98 billion, a PE ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is 25.82%.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts recently commented on CI shares. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Finally, Cantor Fitzgerald lifted their target price on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.